GHK-Cu


Overview

GHK-Cu is a copper-binding tripeptide naturally present in human plasma, saliva and urine — and its levels decline sharply with age, from about 200 ng/mL at age 20 to 80 ng/mL by 60. It was discovered by Loren Pickart in 1973 and has become a cornerstone of cosmetic and regenerative peptide use.

Unlike most grey-market peptides, GHK-Cu has decades of published research and is a legitimate cosmetic ingredient in topical products worldwide.

How It Works

GHK-Cu is a master regulator of tissue remodeling. Gene expression studies show it modulates thousands of human genes — broadly shifting cells toward a healthier, more youthful expression pattern. It stimulates collagen, elastin and glycosaminoglycan synthesis while activating metalloproteinases that clear damaged proteins.

Copper delivery

The peptide is also a copper courier, delivering this essential cofactor to enzymes like lysyl oxidase (collagen crosslinking) and superoxide dismutase (antioxidant defense). Both the peptide sequence and the copper matter.

Key Benefits

Skin rejuvenation — the best-documented effect: improved firmness, reduced wrinkles, better density in cosmetic trials.

Wound healing — accelerated healing and reduced scarring in animal and in vitro models.

Hair growth — follicle stimulation documented in cosmetic research; a common ingredient in hair serums.

Anti-inflammatory and antioxidant — broad protective gene expression effects.

Side Effects & Considerations

Topical GHK-Cu is very safe — it is in commercial cosmetics. Injectable use is the grey-market route and carries the standard unknowns, plus a specific one: copper balance. Chronic high-dose copper delivery could theoretically disturb copper/zinc equilibrium.

Practical guidance

For skin goals, topical products with verified GHK-Cu content are the evidence-based route. Injectable use for systemic regeneration is popular but rests on mechanistic extrapolation rather than human trials. Quality topical products and quality injectable sourcing are both non-trivial — copper peptides degrade and oxidize easily.

Dosage protocols

Protocol Dosage Frequency Duration Notes
Topical (evidence-based) 0.05-2% cream or serum 1-2 times daily Ongoing The route with actual human cosmetic data.
Injectable (anecdotal) 1-2 mg Daily or every other day 4-6 weeks Subcutaneous. Community protocol without human trial support.

Warnings

Topical use is well established; injectable use is not. Watch copper balance with chronic injectable use. Product quality and stability vary widely.